Your session is about to expire
← Back to Search
Morphine for Blood Cancers
Study Summary
This trial is testing whether levorphanol can help reduce pain in cancer patients who have tried other opioids.
- Blood Cancers
- Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this study the inaugural research of its type?
"Currently, 123 trials assessing the medical efficacy of Morphine are being conducted in 311 cities and 36 countries. The initial investigation into this drug was sponsored by Merck Sharp & Dohme LLC in 2005 with 80 participants involved up until Phase 4 approval. Since then, 1295 separate studies have been completed."
Can you provide a synopsis of other experiments conducted involving Morphine?
"At present, 123 ongoing clinical trials for Morphine are underway with 29 in their third phase. Although the majority of these studies are taking place in Boston, Massachusetts, there exists a total of 652 sites conducting research on this medication."
What therapeutic objectives is Morphine typically employed to address?
"Morphine can be employed to address peripheral vascular disease, neuropathic pain, and other medical procedures."
How many individuals have been recruited for this clinical trial thus far?
"This medical trial is not actively accepting participants at the moment. It was first posted on November 29th 2018 and last updated June 29 2022. If you are seeking other studies, there are 2436 clinical trials recruiting patients with lymphoid cells and 123 trials for Morphine currently enrolling volunteers."
Are there still opportunities for individuals to join this testing program?
"This research is no longer in need of participants. It was first posted on November 29th 2018, and last edited on June 29 2022. For individuals searching for alternate trials, 2436 studies recruiting lymphoid cells are currently enrolling candidates, while 123 separate Morphine related clinical studies remain active."
Share this study with friends
Copy Link
Messenger